advanced search
Dr Fred Metzmann
Senior Advisor Portfolio Management
Haselmeier

Is this your profile?

About

Fred Metzmann, PhD, joined Haselmeier in July 2016 as Vice-President of Sales and Marketing. Previously, he held various leadership positions in the materials and plastics processing industry at Ticona, Celanese, Nypro (now Jabil Healthcare), Sanner and Medisize (now Phillips-Medisize). Based on his in-depth knowledge of the drug delivery device and combination product market with more than 25 years of experience in the field, Dr Metzmann was appointed to the strategic role of Director Portfolio & Product Management in 2020 and assumed his current position as Senior Advisor Portfolio Management of Haselmeier, a medmix brand, in 2021.

Dr Metzmann graduated in chemistry from Johannes Gutenberg University in Mainz (Germany) and earned his doctorate at the Max Planck Institute for Polymer Research in Mainz.

Contributions

#138_2022_Oct_Haselmeier_featured
INJECTION
ADVANCED DELIVERY DEVICE TECHNOLOGY TO SIMPLIFY THE RECONSTITUTION OF LYOPHILISED DRUGS
Fred Metzmann and Chris Muenzer present Haselmeier’s innovative approach to the development of reconstitution devices that allow easy and convenient administration of freeze-dried biologics.

More contributions

#133_2022_May_Injectables_Haselmeier_Featured1
INJECTION
EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM
Fred Metzmann and Chris Muenzer discuss the simplicity of the PiccoJect™ autoinjector platform and the company's commitment to sustainability.
CONNECTIVITY
D-FLEX® ECOSYSTEM – FROM DATA TO VALUE
Fred Metzmann and Frank Leipold discuss the benefits of connected medical devices in clinical trials and describe the advantages of Haselmeier's D-Flex® Ecosystem for improving adherence and reducing the dropout rate in clinical trials.
INJECTION
DEVELOPMENTS IN SELF-INJECTION DEVICES FOR COMBINATION PRODUCTS
Fred Metzmann reports on the latest state-of-the-art developments in innovative injection devices for combination products in subcutaneous self-application. He outlines Haselmeier's product platform strategy for single-use (D-Flex) and re-usable (i-pen²) injection-pen systems, and related services and looks at the company’s connected digital solutions.
Top